Immunotherapy in reducing clinical symptoms of children with house dust mite-induced allergic rhinitis

Lutvia Hidayati; Anang Endaryanto; Cita Rosita Sigit Prakoeswa

doi:10.53730/ijhs.v6nS1.6741

Authors

Lutvia Hidayati
lutviahidayati@gmail.com
Department of Child Health, Faculty of Medicine, Universitas Airlangga, Surabaya, East Java, Indonesia
Anang Endaryanto Department of Child Health, Faculty of Medicine, Universitas Airlangga, Surabaya, East Java, Indonesia
Cita Rosita Sigit Prakoeswa Department of Dermatology and Venereology, Faculty of Medicine, Universitas Airlangga, Surabaya, East Java, Indonesia

Keywords:

Allergic rhinitis, house dust mite, immunotherapy, children, symptom score, medication score

Abstract

Allergic rhinitis in children is mostly caused by house dust mites (HDM). It requires long-term therapy and decreases the quality of life of patients and their caregivers. Immunotherapy provides long-term improvement of clinical symptoms in children with allergic rhinitis. However, there are not many studies on the benefit of immunotherapy in children with allergic rhinitis in Indonesia. This study aimed to analyze the benefits of immunotherapy in reducing clinical symptoms in children with HDM-induced allergic rhinitis. A secondary data-based retrospective cohort study was conducted on HDM-induced allergic rhinitis children between 2015-2019 in Surabaya. The diagnosis of HDM-induced allergic rhinitis was established from typical allergic symptoms and a positive skin prick test result for HDM allergens. The improvement of clinical symptoms was assessed based on total symptom score (TSS), total medication score (TMS), and combination of symptom and medication score (CSMS) of the EAACI/WAO scoring. Observation on each score was carried out at the time of initial diagnosis and after 18 months of therapy. Mann-Whitney comparative analysis statistical test was for comparing immunotherapy group and non-immunotherapy group. TSS, TMS, and CSMS of the immunotherapy group were significantly lower (p<0.05) than in the non-immunotherapy group.

Downloads

Download data is not yet available.

References

Brożek JL, Bousquet J, Baena-Cagnani CE, Bonini S, Canonica GW, and Casale TB. Allergic rhinitis and its impact on asthma (ARIA) 2010 revision. J Allergy Clin Immunol. 2010; 126:466-76.

Calderón MA, Kleine-Tebbe J, Linneberg A, Blay FD, Rojas DHF, and Virchow JC. House dust mite respiratory allergy: an overview of current therapeutic strategies. J Allergy Clin Immunol Pract. 2015; 3:843-55.

Eifan AO, Akkoc T, Yildiz A, Keles S, Ozdemir C, Bahceciler NN, and Barlan IB. Clinical efficacy and immunological mechanisms of sublingual and subcutaneous immunotherapy in asthmatic/rhinitis children sensitized to house dust mite: an open randomized controlled trial. Clin Exp Allergy. 2010; 40:922-32.

Eifan AO, Akkoc T, Yildiz A, Keles S, Ozdemir CC, Bahceciler NN, and Barlan IB. Clinical efficacy and immunological mechanisms of sublingual and subcutaneous immunotherapy in asthmatic/rhinitis children sensitized to house dust mite: an open randomized controlled trial. Clin Exp Allergy. 2010; 40:922-32.

Endaryanto A and Nugraha RA. Indonesia-based study of the clinical and cost-saving benefits of subcutaneous allergen immunotherapy for children with allergic rhinitis in private practice. Cells. 2021; 10:184167.

Endaryanto A. Implikasi klinis imunologi alergi dalam manajemen anak alergi. Surabaya: Airlangga University Press (AUP). 2015; 122-212.

Karakoc-Aydiner E, Eifan AO, Baris S, Gunay E, Akturk H. Long-term effect of sublingual and subcutaneous immunotherapy in dust mite-allergic children with asthma/rhinitis: a 3-year prospective randomized controlled trial. J Investig Allergol Clin Immunol. 2015; 25:334-42.

Kurukulaaratchy RJ, Karmaus W, Raza A, Matthews S, Roberts G, and Arshad SH. The influence of gender and atopy on the natural history of rhinitis in the first 18 years of life. Clin Exp Allergy. 2011; 41:851–59.

Marinho S, Simpson A, Lowe L, Kissen P, Murray C, and Custovic A. Rhinoconjunctivitis in 5-year- old children: a population-based birth cohort study. Allergy. 2007; 62:385–93.

Marino-Sanchez, F., M. Valls-Mateus, G. de los Santos, A.M. Plaza, I. Cobeta, and J. Mullol. 2019. Multimorbidities of pediatric allergic rhinitis. Curr Allergy Asthma Rep. 19:13-24.

Meadows A, Kaambwa B, Novielli N, Huissoon A, Fry-Smith A, and Meads C. A systematic review and economic evaluation of subcutaneous and sublingual allergen immunotherapy in adults and children with seasonal allergic rhinitis. Health Technol Assess. 2013; 17:11-4.

Nevis IF, Binkley K, and Kabali C. Diagnostic accuracy of skin prick testing for allergic rhinitis: a systematic review and meta-analysis. Allergy Asthma Clin Immunol. 2016; 12:20-32.

Pfaar, O, Demoly P, Gerth van Wijk R, Bonini S, Bousquet J, Canonica GW, and Durham SR. Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper. Allergy. 2014; 69:854-67.

Tschopp JM, Sistek D, Schindler C, Leuenberger P, Perruchoud AP. Current allergic asthma and rhinitis: diagnostic efficiency of three commonly used atopic markers (IgE, skin prick tests, and Phadiatop). Results from 8329 randomized adults from the SAPALDIA Study. Swiss Study on Air Pollution and Lung Diseases in Adults. Allergy. 1998; 53: 608–13.

World Allergy Organization (WAO). White Book on Allergy: Update 2013. World Allergy Organization. Milwaukee. 2013; 2: 21-2.

Yang, L.F., L.M. Cai, M. Li, J.T. Liu, Z.N. Wang, W.H. Wang, Q.T. Yang, and Z.G. Chen. 2018. A 10-year retrospective study of alterative aeroallergens sensitization spectrum in urban children with allergic rhinitis. Ther Clin Risk Manag. 14:409-16.

Yao TC, Ou LS, Yeh KW, Lee WI, Chen LC, Huang JL, and PATCH Study Group. Associations of age, gender, and BMI with prevalence of allergic diseases in children: PATCH study. J Asthma. 2011; 48:503-10.